WO2016118040A8 - Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий - Google Patents
Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий Download PDFInfo
- Publication number
- WO2016118040A8 WO2016118040A8 PCT/RU2015/000034 RU2015000034W WO2016118040A8 WO 2016118040 A8 WO2016118040 A8 WO 2016118040A8 RU 2015000034 W RU2015000034 W RU 2015000034W WO 2016118040 A8 WO2016118040 A8 WO 2016118040A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gels
- lidocaine hydrochloride
- properties
- gel
- nanotechnology
- Prior art date
Links
- 229960004393 lidocaine hydrochloride Drugs 0.000 title abstract 4
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 title abstract 4
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001597 nifedipine Drugs 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000000499 gel Substances 0.000 abstract 8
- 206010002153 Anal fissure Diseases 0.000 abstract 2
- 208000016583 Anus disease Diseases 0.000 abstract 2
- 208000009531 Fissure in Ano Diseases 0.000 abstract 2
- 208000014617 hemorrhoid Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000004321 preservation Methods 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 238000009533 lab test Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000035807 sensation Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU2015/000034 WO2016118040A1 (ru) | 2015-01-21 | 2015-01-21 | Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU2015/000034 WO2016118040A1 (ru) | 2015-01-21 | 2015-01-21 | Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2016118040A1 WO2016118040A1 (ru) | 2016-07-28 |
| WO2016118040A8 true WO2016118040A8 (ru) | 2016-10-06 |
Family
ID=56417452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/RU2015/000034 Ceased WO2016118040A1 (ru) | 2015-01-21 | 2015-01-21 | Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2016118040A1 (un) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2684326C1 (ru) * | 2017-11-15 | 2019-04-08 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) | Способ получения геля нифедипина |
| IT201800002413A1 (it) * | 2018-02-05 | 2019-08-05 | Carmine Antropoli | "composizione a base di nifedipina per uso nel trattamento delle ragadi anali e proctalgie" |
| BR102018008324A2 (pt) | 2018-04-25 | 2019-11-05 | Laboratorios Ferring Ltda | composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico |
| CN112423736A (zh) | 2018-06-01 | 2021-02-26 | 塔凡塔医疗匈牙利公司 | 用于治疗肛门直肠疾病的局部氨氯地平盐 |
| JP7331149B2 (ja) * | 2019-02-25 | 2023-08-22 | ノヴァメディカ リミテッド ライアビリティー カンパニー | 直腸および局所投与のためのゲル |
| RU2733080C1 (ru) * | 2019-12-13 | 2020-09-29 | Александр Евгеньевич Баранников | Фармакологическая композиция для лечения проктологических заболеваний (варианты). |
| EP4312984A4 (en) * | 2021-04-01 | 2025-02-19 | Steel Therapeutics, Inc. | TOPICAL WIPE CONTAINING NIFEDIPINE AND LIDOCAINE |
| CN113679663B (zh) * | 2021-10-09 | 2023-09-29 | 海南回元堂药业有限公司 | 一种斑蝥素乳膏及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002064802A (ja) * | 2000-08-21 | 2002-02-28 | Sony Corp | データ伝送システム、データ伝送装置及び方法、シーン記述処理装置及び方法 |
| US9107815B2 (en) * | 2008-02-22 | 2015-08-18 | Allergan, Inc. | Sustained release poloxamer containing pharmaceutical compositions |
| RU2483721C1 (ru) * | 2012-05-17 | 2013-06-10 | Общество с ограниченной ответственностью "Общество лабораторных исследований медицинских препаратов" | Лекарственная композиция на основе тизоля для лечения анальных трещин |
-
2015
- 2015-01-21 WO PCT/RU2015/000034 patent/WO2016118040A1/ru not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016118040A1 (ru) | 2016-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2016118040A8 (ru) | Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий | |
| EA201892395A1 (ru) | Лекарственные составы ингибитора lsd1 | |
| EP4353257A3 (en) | Method for producing rna compositions | |
| WO2018089851A3 (en) | Influenza vaccine | |
| WO2018115527A3 (en) | Mers coronavirus vaccine | |
| HK1247850A1 (zh) | Pd-1 拮抗剂与egfr 抑制剂的组合 | |
| HK1251481A1 (zh) | 使用白介素-17(il-17)拮抗剂治疗放射学阴性中轴型脊柱关节炎的方法 | |
| EP4548972A3 (en) | (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase i inhibitors | |
| ZA202105976B (en) | Pharmaceutical dosage form for application to mucous membranes and methods for producing same | |
| EA201791537A1 (ru) | Фармацевтическая композиция на основе наночастиц доцетаксела-альбумина, способ ее получения и ее применение | |
| EA201490653A1 (ru) | Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств | |
| EA201590491A1 (ru) | Иммуногенная композиция | |
| WO2013188268A8 (en) | Topical ophthalmological pharmaceutical composition containing pazopanib | |
| WO2015056094A3 (en) | Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent | |
| RU2019110980A (ru) | Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением | |
| EP4477265A3 (en) | Methods of treating new-onset plaque type psoriasis using il-17 antagonists | |
| WO2014203275A3 (en) | An improved process for the preparation of apixaban and intermediates thereof | |
| AR091724A1 (es) | Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fampridina, composicion farmaceutica | |
| PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
| TN2015000280A1 (en) | Topical Ophthalmological Pharmaceutical Composition containing Regorafenib | |
| CO7131356A2 (es) | Método para producir clorhidrato de anamorelina que tiene contenido controlado de cloruro | |
| EA201391742A1 (ru) | Фармацевтическая композиция, включающая фексофенадин | |
| WO2013188279A8 (en) | Topical ophthalmological pharmaceutical composition containing cediranib | |
| EA201891805A1 (ru) | Способ | |
| JP2017517574A5 (un) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15879121 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 15879121 Country of ref document: EP Kind code of ref document: A1 |